[Augmentation of natural killer (NK) cell activity in human blood lymphocytes by a new synthetic acyltripeptide (FK-565) and its derivatives].
Natural killer (NK) activities of human blood lymphocyte populations that were depleted of monocytes by centrifugal elutriation, were significantly augmented by in vitro treatment with synthetic acyltripeptide (FK-565) at concentrations ranging from 10 micrograms/ml to 100 micrograms/ml in medium. Of FK-565 and its eight derivatives, FR-39868 was the most effective in potentiating human NK cell activity, and caused NK cell-mediated cytotoxicity against K-562 target cells even at a minimal concentration of 1 microgram/ml. The significant levels of cytotoxicity, increased with increasing NK cell/target ratio. These results indicate that acyltripeptide and its derivatives should be useful in enhancing natural host defense against neoplasias in vivo.